Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Sell
47
AIMD Quote, Financials, Valuation and Earnings
Last price:
$0.53
Seasonality move
:
54%
Day range:
$0.50 - $0.55
52-week range:
$0.40 - $4.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
39.38x
P/B ratio:
0.41x
Volume:
144.2K
Avg. volume:
119.8K
1-year change:
-73.07%
Market cap:
$7.3M
Revenue:
$122.1K
EPS (TTM):
-$2.80
Analysts' Opinion
-
Consensus RatingAinos has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Ainos has an estimated downside of -- from its current price of $0.53.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $0.53.
Fair Value
-
According to the consensus of 0 analysts, Ainos has -- downside to fair value with a price target of -- per share.
AIMD vs. S&P 500
-
Over the past 5 trading days, Ainos has overperformed the S&P 500 by 11.01% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Ainos does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ainos revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Ainos reported revenues of $20.7K.
Earnings Growth
-
Ainos has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Ainos reported earnings per share of -$0.33.
Enterprise value:
14.4M
EV / Invested capital:
--
Price / LTM sales:
39.38x
EV / EBIT:
--
EV / Revenue:
154.11x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2.28x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$143.3K
Return On Assets:
-43.82%
Net Income Margin (TTM):
-15547.98%
Return On Equity:
-52.95%
Return On Invested Capital:
-45.16%
Operating Margin:
-15051.82%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $2.5M | $1.1M | -- | $24.5K | -- | |
| Gross Profit | $962.1K | $317.5K | -$143.3K | -$63.4K | -$550 | |
| Operating Income | -$13.3M | -$9.6M | -$14.9M | -$2.7M | -$3M | |
| EBITDA | -$8.8M | -$5M | -$10.8M | -$1.7M | -$2.2M | |
| Diluted EPS | -$5.40 | -$1.93 | -$2.80 | -$0.73 | -$0.33 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $157.9K | $884.8K | $3.7M | $3M | $5.6M | |
| Total Assets | $301.3K | $20M | $39.1M | $33.9M | $31.4M | |
| Current Liabilities | $1.1M | $2.8M | $2.6M | $819.5K | $4.1M | |
| Total Liabilities | $1.1M | $2.9M | $2.7M | $6.2M | $13.3M | |
| Total Equity | -$776.5K | $17.1M | $36.4M | $27.7M | $18M | |
| Total Debt | $632.8K | $2.2M | $1.3M | $5.3M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$3.1M | -$3.9M | -$6.3M | -$743.3K | -$1.5M | |
| Cash From Investing | -$802.3K | -$82.6K | -$122.6K | -$46.3K | -$18.8K | |
| Cash From Financing | $5.7M | $4M | $9.2M | $1.8M | -$1.5M | |
| Free Cash Flow | -$3.9M | -$4M | -$6.3M | -$779.9K | -$1.5M | |
AIMD
Sector
Market Cap
$7.3M
$48.6M
Price % of 52-Week High
12.34%
47.39%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-73.07%
-33.25%
Beta (5-Year)
1.415
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$0.48
200-day SMA
Sell
Level
$0.72
Bollinger Bands (100)
Buy
Level
0.44 - 0.58
Chaikin Money Flow
Sell
Level
-101.7M
20-day SMA
Buy
Level
$0.46
Relative Strength Index (RSI14)
Buy
Level
65.58
ADX Line
Buy
Level
27.51
Williams %R
Sell
Level
-15.4688
50-day SMA
Buy
Level
$0.47
MACD (12, 26)
Sell
Level
0.01
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
275.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.2531)
Sell
CA Score
(Annual)
Level (-0.6082)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (3.6091)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
Stock Forecast FAQ
In the current month, AIMD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AIMD average analyst price target in the past 3 months is --.
-
Where Will Ainos Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ainos share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Ainos?
Analysts are divided on their view about Ainos share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ainos is a Sell and believe this share price will rise from its current level to --.
-
What Is Ainos's Price Target?
The price target for Ainos over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AIMD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ainos is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of AIMD?
You can purchase shares of Ainos via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ainos shares.
-
What Is The Ainos Share Price Today?
Ainos was last trading at $0.53 per share. This represents the most recent stock quote for Ainos. Yesterday, Ainos closed at $0.53 per share.
-
How To Buy Ainos Stock Online?
In order to purchase Ainos stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Carlos Slim Buy PBF Energy?
Carlos Slim made a splash in a surprising sector last…
Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Sell
47
DRUG alert for Jan 4
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Buy
85
BMA alert for Jan 4
Banco Macro SA [BMA] is up 0.88% over the past day.
Sell
47
AGFY alert for Jan 4
Agrify [AGFY] is down 5.86% over the past day.
